NCT03748134 2023-10-24Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )Innovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed746 enrolled
NCT00705016 2014-04-30ADVANTAGEMerck KGaA, Darmstadt, GermanyPhase 1/2 Completed184 enrolled 20 charts